Assignee
JACOBIO PHARMACEUTICALS CO LTD
CN·16 granted patents·22 pending applications·88 citations·filing 2017–2024
Top patents by PatentIndex Score
38 records- 0193US11174319B2Binding molecule specific for CD73 and use of binding moleculeJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 16, 2021·8 cites·19 claims
- 0293US10988466B2Heterocyclic derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2018·Granted Apr 27, 2021·37 cites·2 claims
- 0393US10858359B2Heterocyclic ring derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2017·Granted Dec 8, 2020·37 cites·2 claims
- 0492US11180506B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 23, 2021·3 cites·2 claims
- 0591US11466005B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 11, 2022·2 cites·8 claims
- 0684US11161847B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 2, 2021·1 cites·2 claims
- 0775US12233062B2Heterocyclic derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Granted Feb 25, 2025·0 cites·11 claims
- 0874US12195473B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 14, 2025·0 cites·10 claims
- 0974US2025011327A1Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1073US11136320B2Fused ring derivative used as FGFR4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 5, 2021·0 cites·2 claims
- 1172US2025223285A1Novel heterocyclic derivatives useful as shp2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1269US11787811B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 17, 2023·0 cites·15 claims
- 1368US11384066B1Heterocyclic compounds useful as aurora a selective inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Jul 12, 2022·0 cites·4 claims
- 1468US2022119386A1Fused ring derivative used as fgfr4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1564US11345701B1KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted May 31, 2022·0 cites·10 claims
- 1662US2026098039A1Solid forms of compound i or salts thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1761US12103929B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 1, 2024·0 cites·20 claims
- 1860US2022064322A1Binding molecule specific for cd73 and use of binding moleculeJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1960US2024376128A1N-cyclopropylpyrido [4, 3-d] pyrimidin-4-amine derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2059US2024376075A1Polymorphic forms of aurora a selective inhibitors and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2159US2025019377A11, 4-oxazepane derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2259US2025108123A1Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2359US2025034166A1Polycyclic fused ring derivatives and use thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2458US2023128198A1Novel heterocyclic compounds useful as aurora a selective inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2558US2021163478A1Fused ring derivative used as fgfr4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 2657US2024400591A1Compounds targeting mutant of p53JACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2757US2024336629A1Tricyclic Derivatives Useful As PARP7 InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2857US2024116909A1Novel compounds useful as sting agonists and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2957US2024199548A1Novel compounds useful as sting agonists and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 3057US2024199644A1Fused Ring Derivatives Useful as KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 3155US2024025918A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3255US2024059710A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3355US2021393623A1Novel Heterocyclic Derivatives Useful as SHP2 InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 3454US12281168B2Binding molecule specific for LIF and use thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Apr 22, 2025·0 cites·9 claims
- 3552US12577201B2Glutamine analogsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Mar 17, 2026·0 cites·4 claims
- 3649US12391756B2Binding molecule specific for CD39 and use thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Granted Aug 19, 2025·0 cites·20 claims
- 3749US2021040089A1Kras mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3848US2021094919A1Kras mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JACOBIO PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →